MFAP1

Microfibrillar-associated protein 1 · P55081 · MFAP1 on Sugi Atlas →

0 patent compounds predicted against MFAP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MFAP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Deflazacort in Dysferlinopathies PHASE2/PHASE3COMPLETED
Losartan Versus Atenolol for the Treatment of Marfan Syndrome PHASE2COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure? nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Observational Cohort Study of Dysferlinopathy in China nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC) nanRECRUITING
Linkage Study in Familial Pulmonary Fibrosis nanCOMPLETED
Longitudinal Biomarkers With Selected Outcome Measures In CMT nanRECRUITING
Genetic Markers for Focal Segmental Glomerulosclerosis nanCOMPLETED
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2 nanRECRUITING
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers nanACTIVE_NOT_RECRUITING
Study of Proteus Syndrome and Related Congenital Disorders nanRECRUITING
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Characteristics of Nondystrophic Myotonias nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker) nanCOMPLETED
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis nanRECRUITING
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases nanCOMPLETED
Short Interval Resveratrol Trial in Cardiovascular Surgery nanACTIVE_NOT_RECRUITING
Genetic Analysis of Familial Hypertrophic Cardiomyopathy nanCOMPLETED
CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberrant Nerve Sprouting nanUNKNOWN
Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches nanRECRUITING
Evaluation of the Role of Neurodegeneration in Schizophrenia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MFAP1 binder may also engage these)

ProteinNameSimilarity
Q5EA98 1.000 Q5EA98 →
C0HKD9 1.000 C0HKD9 →
C0HKD8 1.000 C0HKD8 →
Q93712 1.000 Q93712 →
Q9W062 0.999 Q9W062 →
P55080 0.997 P55080 →
Q6FJP1 0.992 Q6FJP1 →
P0CR52 0.992 P0CR52 →
Q3KQD1 0.991 Q3KQD1 →
O48713 0.991 O48713 →
Q9LFE0 0.991 Q9LFE0 →
P78794 0.991 P78794 →
P41880 0.990 P41880 →
P53064 0.990 P53064 →
A8XXB0 0.990 A8XXB0 →
Q9P7H6 0.989 Q9P7H6 →
P38326 0.989 P38326 →
Q9N4U5 0.989 Q9N4U5 →
O02327 0.989 O02327 →
O13910 0.989 O13910 →
Q751U1 0.988 Q751U1 →
Q93591 0.988 Q93591 →
Q9ULR0 0.988 Q9ULR0 →
Q9USV4 0.988 Q9USV4 →
Q09252 0.988 Q09252 →
P39964 0.988 P39964 →
O94667 0.988 O94667 →
F4HVZ5 0.988 F4HVZ5 →
Q9VAQ7 0.988 Q9VAQ7 →
Q9VWD4 0.988 Q9VWD4 →